Second Heart Assist

Executive Summary

Second Heart Assist is a private medical device company headquartered in Salt Lake City, Utah, founded in 2015. The company specializes in developing minimally invasive cardiac assist devices for patients with heart failure, aiming to provide innovative circulatory support solutions that are less invasive than traditional surgical options. While the company has not publicly disclosed its funding rounds, revenue, or clinical stage, its focus on addressing the growing heart failure epidemic positions it within a large and expanding market. The absence of detailed financial or clinical data limits visibility into its operational progress, but the company's entry into the cardiovascular device space underscores the potential demand for less invasive heart failure therapies. Given the lack of public milestones, the company remains an early-stage venture with unproven technology, requiring further validation through clinical trials or regulatory clearances.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance or IDE Approval for Lead Device40% success
• Q2 2026Announcement of Series A or B Funding Round50% success
• Q4 2026Publication of Preclinical or Early Clinical Data35% success